Around 400,000 children and adolescents aged 0–19 develop cancer annually, with leukemias, brain tumors, and lymphomas leading causes; survival exceeds 80% in high-income countries but falls below 30% in low- and middle-income countries (LMICs).
Disparities Driven by Access Barriers
LMIC deaths stem from delayed/misdiagnosis, treatment abandonment, toxicity, and relapse; only 29% of low-income nations stock essential cancer drugs versus 96% in high-income ones. Early detection, generic meds, surgery, and radiotherapy can cure most if accessible.
Prevention Limited, Focus on Early Care
Unlike adult cancers, childhood cases rarely link to lifestyle/environment (10% genetic predisposition); infections like HIV raise risks in LMICs. Early symptoms—fever, headaches, bone pain—demand prompt primary care evaluation.
WHO Global Initiative Targets 60% Survival by 2030
Launched 2018 with St. Jude, the CureAll framework aids capacity building; Global Platform ensures medicine access, emphasizing palliative care and data systems for equity.
